ENTERO · Health Care · 2026-08-21

Entero Healthcare Solutions Ltd

8.3★★★ PrimeStrong +13.2Stage 2 · wk 2In scan: Prop Scan · Breakout Watch · Pullback HunterMARKET: BULL RISING · 2026-08-21
₹1,423.6
+1.08% today
₹6,196 Cr · Mid cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthcare products, including pharmaceutical and nutraceutical products, vaccines, medical devices, such as orthopaedic implants and coronary stents, and hospital consumables comprising examination and surgical gloves, syringes, needles and sutures to hospitals, retail pharmacies, healthcare product manufacturers, and healthcare clinics. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.

Visit company website →
P/E (TTM)
44.8
Forward 21.5
Earnings Growth (YoY)
+8.6%
Revenue +25.6%
vs 52W High
-1.7%
₹949.2 lo₹1,448 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 2
1w13w26w
Week 2 — fresh breakout, verify structure
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
23.1%
200 DMA: ₹1,156.3 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.77x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑ ⇈
Accelerating · MA20 +7.6% vs MA50 +4.3% / 10d
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #42 of 84 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↑ Building
Stage 2%
56.1%
20d Δ
+5.6pp
1M return
+2.7%
3M return
+10.4%
Industry Stage-2 % · last 20 days
Ranks #33 of 58 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2024-02-16 → 2026-08-21
S? 43w
S4 17w
S1 13w
2024-02-162026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 43w → S3 1w → S2 5w → S3 8w → S4 8w → S1 7w → S4 9w → S1 3w → S4 17w → S1 13w → S2 9w → S3 7w → S2 1w current
Total tracked: 131 weeks across 13 stage runs.
1M
+18.0%
3M
+5.1%
6M
+29.7%
YTD
+50.0%
1Y
+17.9%
Scan Membership
Prop Scan
Latest: 2026-08-21
Breakout Watch
Latest: 2026-08-12
Pullback Hunter
Latest: 2026-05-26
34 appearances in last 60 days. First seen: 2024-12-19.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 2 · Vol —x
2026-08-20S2
Wk 2 · Vol —x
2026-08-19S2
Wk 2 · Vol —x
2026-08-18S2
Wk 1 · Vol —x
2026-08-17S2
Wk 1 · Vol —x
2026-08-14S2
Wk 1 · Vol —x
2026-08-13S2
Wk 1 · Vol —x
2026-08-12S23→2
Wk 1 · Vol —x
2026-08-11S3
Wk 7 · Vol —x
2026-08-10S3
Wk 7 · Vol —x
2026-08-07S3
Wk 7 · Vol —x
2026-08-06S3
Wk 7 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹1,237.1
200 DMA
₹1,156.3
52W High
₹1,448
52W Low
₹949.2
5D Low
₹1,386.8
Resistance levels (recent highs)
20d High
₹1,448
60d High
₹1,448
120d High
₹1,448
250d High
₹1,448
Next resistance
+1.7%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.